Skip to main content

Correction: Testicular cancer in mice: interplay between stem cells and endocrine insults

The Original Article was published on 08 June 2022

Correction: Stem Cell Research & Therapy (2022) 13:243 https://doi.org/10.1186/s13287-022-02784-5

Following the publication of our article [1], readers noted that one Figure was placed at two places (Figs. 3d and 6e) and also there was partial overlap between Fig. 3g and 6d. Figure 3d was placed incorrectly due to unintentional human error. Figures 3g and 6d represent same experimental conditions and observations. The corrections have now been incorporated in Figs. 3d and 3g; Fig. 3 has been modified and given below with modified (underlined) legend while Fig. 6 remains unchanged. The changes do not change the results and conclusions of the original study.

Fig. 3
figure 3

Neonatal exposure to DES resulted in bigger size testes on day 100. Bigger testis showed completely disrupted histo-architecture (a). Seminiferous tubules were markedly reduced, occluded, and without a defined membrane, and germ cells were depleted (d, e, g). Sertoli cells were also not observed (d–k). Massive inflammation was observed in testes (i). Degeneration of germ cells was observed. GCNIS-like stem cells were clearly observed restricted to small seminiferous tubules (d, e, f, g). Small, spherical putative stem cells were present among the inflammatory cells (h, i, l). Multinuclear giant cells were observed (b, c). Scale: (a:100 μm, k-l: 20 μm)

Reference

  1. Kaushik A, Bhartiya D. Testicular cancer in mice: interplay between stem cells and endocrine insults. Stem Cell Res Ther. 2022;13(1):243. https://doi.org/10.1186/s13287-022-02784-5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepa Bhartiya.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaushik, A., Bhartiya, D. Correction: Testicular cancer in mice: interplay between stem cells and endocrine insults. Stem Cell Res Ther 14, 274 (2023). https://doi.org/10.1186/s13287-023-03510-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-023-03510-5